U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06874894) titled 'Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)' on March 08.
Brief Summary: This study was design to investigate the efficacy and safety of NOAC therapy in Koreans
Study Start Date: May 25, 2022
Study Type: OBSERVATIONAL
Condition:
Fibrillation, Atrial
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Information provided by (Responsible Party): Ki-Woon Kang, Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Published by HT Digital Content Services with per...